Pharming Group N.V.

NASDAQ: PHAR · Real-Time Price · USD
14.05
-0.55 (-3.77%)
At close: Sep 18, 2025, 3:59 PM
14.05
0.00%
After-hours: Sep 18, 2025, 04:10 PM EDT

Pharming Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
54.94M 61.74M 207.34M 191.72M
Short-Term Investments
112.95M 151.68M n/a n/a
Long-Term Investments
4.23M 10.4M 9.73M 9.95M
Other Long-Term Assets
1.59M 1.62M 1.33M -303.43K
Receivables
50.17M 42.62M 19.58M 15.88M
Inventory
55.72M 51.41M 42.33M 27.28M
Other Current Assets
8.34M 6.53M 213K 227K
Total Current Assets
278.44M 316.34M 277.5M 249.18M
Property-Plant & Equipment
23.3M 33.47M 39.15M 33.13M
Goodwill & Intangibles
61.04M 71.27M 75.12M 83.75M
Total Long-Term Assets
121.55M 146.51M 148.3M 147.72M
Total Assets
399.99M 462.85M 425.8M 396.9M
Account Payables
10.1M 16.02M 6.08M 5.14M
Deferred Revenue
n/a n/a -56.23K -44.35K
Short-Term Debt
4.1M 1.82M 1.77M 2.42K
Other Current Liabilities
n/a 7.74M 1.61M 2.71M
Total Current Liabilities
73.8M 77.97M 59.7M 46.72M
Long-Term Debt
75.44M 136.6M 122.92M 122.13M
Other Long-Term Liabilities
n/a 2.00 8.7M 17.04M
Total Long-Term Liabilities
105.12M 166.1M 161.46M 157.46M
Total Liabilities
178.92M 244.07M 221.16M 204.19M
Total Debt
108.42M 171.54M 166.69M 161.59M
Book Value
221.06M 218.78M 204.64M 192.72M
Book Value Per Share
3.21 3.33 2.32 2.20
Common Stock
7.77M 7.67M 7.51M 7.27M
Retained Earnings
-275.49M -265.26M -256.43M -269.45M
Comprehensive Income
-209K -1.86M -8.74M 2.17M
Shareholders Equity
221.06M 218.78M 204.64M 192.72M
Total Investments
117.18M 162.08M 9.73M 9.95M